Adamalisynes (ADAMs) play an important role in inter-membrane interactions, cell adhesion and fusion processes and protein shedding from the cell surface. Many reports indicate that members of the ADAMs family are overexpressed in human cancer. The aim of the present study was to evaluate ADAM28 and Insulin Like Growth Factor Binding Protein-3 (IGFBP-3)) gene expression in colorectal carcinoma tissues with regard to the overweight or obese status of the patients using an oligonucleotide micro array technique. Fresh tissue specimens were obtained from colorectal cancer patients during surgical treatment. Eighteen specimens from tumour and 18 normal tissue specimens from colorectal cancer patients at clinical stages III and IV were analysed. The examined patients were divided into two groups; those with BMI;::25 and those with normal BMI. The control group consisted of 18 specimens of non-neoplastic colon tissues, which were divided between overweight/obese and normal body weight patients. The gene transcriptional activity from the specimens was analysed using an oligonucleotide microarray technique. Microarrays and rinsing and marking solutions were prepared according to the procedure in the Gene Expression Analysis Technical Manual. The following conclusions were made: i) change of ADAM28 and IGFBP-3 genes expression are present in the normal tissue in overweight/obese patients with colorectal cancer only; ii) the observed molecular variability of ADAM28 and IGFBP-3 expression may be an initial process of cancer proliferation; iii) the histopathologically normal surgical margin in this group of patients was not equal to the molecular margin.
glycoproteins (19 have been identified in humans), containing a metalloproteinase and disintegrin domain that combines both protease and adhesive functions (1) (2) (3) . Adamalisynes play an important role in inter-membrane interactions, cell adhesion and fusion processes and protein shedding from the cell surface. These interactions are significant for both physiological (embryogenesis, angiogenesis) and pathological processes (e.g., carcinogenesis, metastases, Alzheimer's disease and AIDS). There are many reports showing that members of the ADAMs family (ADAM-8, ADAM-9, ADAM-I2, ADAM-15, ADAM-17, ADAM-I9, ADAM-28) are overexpressed in human cancer (3) (4) (5) .
ADAM28 is expressed by human lymphocytes as two isoforms: a membrane-type form (ADAM28m) and a short-secreted form (ADAM28s) (4) (5) (6) (7) (8) . The mRNA expression of ADAM28 is a marker for cell proliferation. ADAM28 is overexpressed in human breast (7) and non-small cell lung cancers, showing a positive correlation with cell proliferation and lymph node metastasis (2, 9) . Overexpression of ADAM28 genes correlates with a high histological grade in conventional chondrosarcoma (10) .
After activation of the precursor with matrix metalloproteinase-7 (MMP-7), ADAM28 releases insulin-like growth factor-l (IGFI) from the IGFI/IGFBP-3 complex by selective digestion of IGFBP-3 into two major fragments. IGF-I induces phosphorylation of IGF-IR and promotes cell proliferation through the ERK pathway (7) . Insulinlike growth factor binding protein-3 suppresses tumour growth and angiogenesis by both IGFdependent and IGF-independent mechanisms (11) . Numerous prospective studies confirm that obesity, hyperinsulinemia, circulating free IGFI, IGF2 and IGFBPs are potential mediators of the association between lifestylefactors and colorectalcancer (12, 13) .
Whether differences exist in IGF system gene expression in cancerous and normal tissue ofpatients with colorectal cancer who are overweight or obese remains unknown. In light ofIGFpleiotropic activity and the dependence on individual and environmental factors, their role in pathophysiological processes remains ambiguous.
The aim of the present study was to evaluate ADAM28 andIGFBP-3 gene expression in colorectal carcinoma tissues with regard to the overweight or obese status of the patients using an oligonucleotide microarray technique.
MATERIALS AND METHODS

Materials
Fresh tissue specimens were taken from colorectal cancer patients (18 cases) during surgery. Eighteen specimens from tumour and 18 specimens from normal tissue of colorectal cancer patients (adenocarcinoma) at clinical stage III and IV were analysed. The examined patients were divided into two groups: nine patients with BMI~25 (labelled 0-WSZ) and nine patients with normal BMI (labelled WSZ). The control group consisted of 18 specimens of non-neoplastic colon tissues taken from the surgical margin of the tumour that were also divided according to overweight/obese (labelled O-K) and normal body weight patients (labelled K). All samples were frozen immediately after surgical removal and stored at -80°C.
Inclusion criteria for the patients were diagnosed and histopathologically confirmed adenocarcinoma of the colon/rectum at clinical stage III and IV (7th edition of UICC TNM classification) and patient's consent.
Exclusion criteria for the colorectal cancer patients were concomitant chronic viral or bacterial diseases, systemic diseases requiring long-term immunosuppression, other diagnosed cancer, carbohydrate metabolism disorders (FGT-fasting glucose tolerance, IGT-impaired glucose tolerance, type 1 or 2 diabetes), and taking non-steroid antiinflammatoryand/or hormonal drugs on a chronic basis.
The study was approved by the Bioethics Committee of the Silesian Medical University in Katowice (NN-6501-79/06).
Methods
The study was carried out in two stages. Firstly, determination of the IGF system genes expressed in the samples of adenocarcinoma of the colorectal and normal tissue taken from the patients who were overweight/ obese. Secondly, evaluation of the activity of IGF system genes in the samples of adenocarcinoma from colorectal and normal tissue in patients with normal body mass.
Molecular analysis
RNA was extracted from the samples with the modified phenol-chloroform method by Chomczynski and Sacchi (14) . After extraction, the RNA purification process was performed with the use of the RNeasy Mini Kit (Qiagen Gmbh, Germany). The isolated and purified RNA was assessed qualitatively and quantitatively. The quantitative evaluation of cDNA and labelled cRNA was generated using the Gene Quant II spectrophotometer, while the quality of the purified RNA was assessed using electrophoretic separation in 1% agarose gel electrophoresis. Next, the transcriptional activity of genes was analysed using the oligonucleotide microarray technique. The process was composed of several stages: hybridisation with a Test3 microarray and then with Human Genome Arrays Ul33A microarrays, and • labelling ofthe obtained hybridisation products with a streptavidin-phycoerythrin dye complex. To enhance the fluorescence signal, biotinylated antibodies were also used. Microarrays, rinsing and marking solutions were prepared according to the procedure of the Gene Expression Analysis Technical Manual (Affymetrix Inc., . California, USA). The labelling of hybridisation products was performed according to the EukGE-WS2v4 protocol recommended for the oligonucleotide microarray HG-U133Ain the Gene Expression Analysis Technical Manual (Affymetrix, CA, USA). The fluorescence intensity was measured with the Agilent GeneArray Scanner G2500A (Agilent Technologies, CA, USA).
there are 22 282 probes for detection of tested mRNA. Only the transcriptional sites associated with the IGF system were analysed. According to the Affymetrix scientific database, 195 genes were selected to analyse the transcriptomes.
Comparison of transcriptomes from the specimens of normal tissue and colorectal cancer (O-K vs O-WSZ) was performed to determine significant differences in gene transcription. Fig. 1 illustrates the distribution of the fluorescence signal depending on the changes in gene expression ofO-K vs 0-WSZ on the basis of negative values of log10 (P-value) versus log 2 (fold change).
Among the 195 genes analysed, initially 131genes had a significant change in fluorescence compared to the control with an FC> 1.1, ofwhich 38 genes had an FC> 1.5. Two genes are statistically significant; thus, their changes are not random (P<O.05) as indicated by the black colour in the Volcano figure (Fig. 1 ). Two genes (FC> 1.1 and P<O.05) were selected for further analysis (Table I) .
The level of gene expression that was significantly differentiated from normal tissue (O-K) was determined according to normalised values of transcriptome fluorescence in all studied specimens 
Statistical analysis
The analysis was carried out with the following software: MicroArray Suite 5.0 and Data Mining Tool (Affymetrix). Normalisation ofresults was performed in the RMA Express Programme, which enabled the assessment of changes in gene transcriptional activity in analysed tissues. For the statistical development of results, Gene Spring software for the microarray data analysis was used. To type the genes of significant differences in transcriptional activity and at the same time of statistical significance, the results were analysed with particular consideration to P-value and fold change (Fe) parameters. The P-value, which should be lower than 0.05, indicates the percentage probability of the accidental occurrence of the observed differences in fluorescence signal. The Fold Change (Fe), which should be higher than 1.1, determines the degree of variation of control fluorescence against the studied transcriptomes.
RESULTS
On an HGU-133A oligonucleotide rmcroarray, (O-WSZ, K and WSZ). The expression level is mapped by the colour intensity (black and dark gray colour in Fig. 2 ). The fluorescence intensity map indicates the differentiated genes in the IGF system. Change of ADAM28 and IGFBP-3 genes expression were observed only in the normal tissue in overweight/obese patients with colorectal cancer.
DISCUSSION
In the overweight and obese patient group, fat tissue is important in the processes of neoplastic transformation. Fat tissue, similar to glandular tissue, is involved in performing the endocrine and paracrine functions, regulating triglyceride metabolism, influencing the coagulation system or inhibiting the anti-lipolytic effect of insulin. This tissue produces many compounds that have diversifiedbiological activities (e.g. tumour necrosis factor alpha, interleukin 6, tumour growth factor beta, insulin-like growth factor I, adiponectin, and leptin) (15) (16) (17) (18) .
In the normal tissue of colorectal cancer patients with BMI2:25, the change of ADAM28 and IGFBP-3 gene expressions (perhaps overexpression and silencing, respectively) was observed, which led to an increase in IGF1 bioactivity in the microenvironment of the tissue. The above-mentioned changes were observed in the histopathologically normal specimen (surgical margin) but not the carcinoma tissue. Notably, the expression of these genes in tumour specimens independently of BMI and normal tissue of the patients with BMI<25 were indistinguishable. ADAM28 gene overexpression in cancerous tissue (breast and lung cancer, chondrosarcoma) has been described by other authors (2-10). However, there were no data about ADAM28 expression in colorectal cancer tissue. In our study, normal expression of ADAM 28 and IGFBP-3 genes in tumours may indicate the presence of reverse processes (necrosis, heterogeneity in the study sample, microenvironmental lesions in the tumour blood circulation, etc.) with no proliferative activity, whereas the altered activity in the genes in the surrounding tissues of the tumour (microscopically normal surgical margin) may suggest proliferation of cancerous cells at the site. Tumour cells could interact with surrounding tissues, initiating the first step in additional cancerous lesion formation. In this case, use of a positive molecular margin in surgery treatment to decrease local recurrence in cancer is discussed. The obtained results constitute the basis for further studies. Confirmation of gene expression using the PCR method, increasing the number of patients in the study and the inclusion of patients at clinical stages I and II are necessary. Microarray analysis is a qualitative rather than quantitative evaluation of mRNA expression. The selected genes from the microarray results should be complemented using the RT-PCRmethod. This study will be will be carried out.
The following conclusions were made: i) Change of ADAM28 and IGFBP-3 gene expression are present in the normal tissue of overweight/obese patients with colorectal cancer only. ii) The observed molecular variability of ADAM28 and IGFBP-3 expression may be an initial process of cancer proliferation. iii) The histopathologically normal surgical margin in this group of patients was not equal to the molecular margin.
